According to Arovella Therapeutics latest financial reports the cash on hand of ALA is $3.50M, an decrease of -14.75% to 2022. At the end of 2022 company had $4.11M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $3.50M | -14.75% |
2022 | $4.11M | -9.62% |
2021 | $4.54M | 587.20% |
2020 | $661.29K | -77.34% |
2019 | $2.92M | - |